BLOOD-RETINAL BARRIER GLUT1 IN DIABETIC RETINOPATHY
BLOOD-RETINAL BARRIER GLUT1 IN DIABETIC RETINOPATHY
批准号:
2668361
负责人:
ARNO K KUMAGAI
金额:
$12.23万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-01 至 2002-02-28
关键词:
animal tissue capillary cell cell interaction diabetes mellitus diabetic retinopathy electron microscopy gene expression genetically modified animals glucose transporter growth factor human tissue in situ hybridization intracellular transport laboratory mouse macrophage mixed tissue /cell culture morphology organ culture pathologic process postmortem radionuclide double label retina circulation transfection vascular endothelium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall objective of the project outlined in the present application
is to provide a mentor-based training program centered around the study
of changes in GLUT1 glucose transporter gene expression in diabetic
retinopathy (DR). The rationale for this project is based on the clinical
observation that the chronic hyperglycemia of long-standing diabetes is
associated with characteristic pathological changes in the retinal
capillaries which comprise the inner blood-retinal barrier (BRB). On a
molecular level, in order to initiate the biochemical and
histopathological changes leading to DR, glucose must gain access to the
intracellular compartment of the capillary endothelial cells of the inner
BRB. It can only do so via transport by GLUT1. Therefore, changes in
GLUT1 expression in the inner BRB may have a profound impact on the
intracellular concentration of glucose and on the subsequent development
of the pathological microvascular changes of DR. A recent pilot study
by the applicant demonstrated a localized, pathological upregulation of
immunoreactive GLUT1 on the inner BRB in long-standing diabetes. The
proposed studies will investigate this phenomenon in 4 general areas.
First, quantitative immunogold electron microscopy and in situ
hybridization for GLUT1 will be performed on postmortem human retina
specimens to extend observations regarding changes GLUT1 protein and mRNA
expression in early DR. Second, selective overexpression of vascular
endothelial GLUT1 in bovine retinal endothelial cells (BRCEC) in culture
and in a transgenic mouse model will be undertaken to determine if
increased expression of GLUT1 results in molecular and histopathological
changes similar to those found in early DR. Third, the effects of glucose
and growth factors associated with the development of DR on GLUT1 gene
expression will be investigated in BRCEC culture models, and fourth,
possible effects of pericyte-endothelial cell interactions on GLUT1 gene
expression will be studied in cell culture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLOOD-RETINAL BARRIER GLUT1 IN DIABETIC RETINOPATHY
-
批准号:2019360
-
项目类别:
-
资助金额:$10.88万
-
财政年份:1997
-
负责人:ARNO K KUMAGAI
-
依托单位:
BLOOD-RETINAL BARRIER GLUT1 IN DIABETIC RETINOPATHY
-
批准号:2882863
-
项目类别:
-
资助金额:$12.49万
-
财政年份:1997
-
负责人:ARNO K KUMAGAI
-
依托单位:
海外基金